Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9600 posts found.

Roche’s ABPI exit – a deliberate snub?

July 3, 2009 Research and Development, Sales and Marketing ABPI, Roche

 By Nicola O’BrienRoche is yet to explain its controversial exit from the ABPI, but the company seems determined to make …
News

Asia Pacific vaccines market requires flexible, targeted portfolios

July 2, 2009 Research and Development, Sales and Marketing Asia, vaccines

Spanning one third of the globe's circumference and home to more than half of the world's population, the Asia Pacific …
News

Onglyza and Cimzia recommended by CHMP

July 2, 2009 Research and Development, Sales and Marketing AZ, BMS, EMEA, Europe, Ongylza

Bristol-Myers Squibb andAstraZeneca's type II diabetes treatment Onglyza is among the brands to have received positive opinions from the Committee …
News

Pfizer halts Sutent colon cancer trial

July 2, 2009 Research and Development, Sales and Marketing Cancer, Pfizer, Sutent

Pfizer has halted a phase III trial for its oncology hope Sutent, after it failed to show significant improvement in …
News

Rovi wins Spanish contract for flu vaccines

July 1, 2009 Manufacturing and Production, Research and Development Europe, Rovi, Spain

News

Sanofi unveils new R&D strategy

July 1, 2009 Research and Development, Sales and Marketing Sanofi-Aventis

News

Roche quits ABPI

June 30, 2009 Research and Development, Sales and Marketing ABPI, Roche, UK

Roche is to give up its ABPI membership in a surprise move that could undermine the UK’s system of industry …
News

Is the law good for your health?

June 30, 2009 Research and Development Les Rose, law, science

 A lawyer once told me that the law has nothing to do with morals. This wasn’t really a surprise, but …
Feature

Bayer signs deal with Celera on cancer targets

June 30, 2009 Research and Development, Sales and Marketing Bayer, Celera

Bayer Schering Pharma has signed a deal with Celera to give it access to five cancer-related targets for therapeutic development …
News

PPD backs away from new facility lease

June 30, 2009 Research and Development CRO, PPD

PPD has cancelled plans to occupy a facility at the North Carolina Research Campus in the US, blaming construction delays …
News

Contract research sector: news in brief

June 29, 2009 Research and Development CRO, chiltern

Pharmafocus presents a round-up of developments in the contract research sector, including a successful IPO by Medidata, Pierrel's imminent acquisition …
News

Novartis gains approval for first Japanese biosimilar

June 25, 2009 Research and Development, Sales and Marketing Novartis, generics

Japan has approved its first biosimilar medicine – the recombinant human growth hormone somatropin from Novartis' generic arm Sandoz. The …
News

Merck takes aim at neglected tropical diseases

June 25, 2009 Research and Development, Sales and Marketing Africa, Merck, Orphan

Merck & Co is participating in two projects designed to help improve healthcare in Africa. The pharma giant will join …
News

GSK signs arthritis drug development collaboration

June 25, 2009 Research and Development, Sales and Marketing Deals, GSK

GlaxoSmithKline and Oxford-based Chroma Therapeutics are linking up to identify small molecule therapeutics in a bid to combat conditions like …
News

NICE rejects Erbitux in head and neck cancer

June 24, 2009 Research and Development, Sales and Marketing Erbitux, Merck Serono, NICE

News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026